Share

|

eAlerts

|

Register

|

Login
Showcase

>

  • Showcases
  • >
  • UEGW 2020 | Ozanimod maintains remission in patients with ulcerative colitis
  • Gastroenterology
  • Conference Coverage & Reporting

UEGW 2020 | Ozanimod maintains remission in patients with ulcerative colitis

Silvio Danese outlines the 52-week TRUE NORTH study findings showing the benefits of ozanimod in patients with moderate-to-severe ulcerative colitis (4:11).

Don’t fall behind!

Get the latest headlines – in your specialties of choice – delivered straight to your inbox.
Register Now

Showcase

Xray image of breast cancer

Beta blockers tied to improved TNBC survival

MEET THE SENIOR TEAM

Lucy Piper

medwireNews Bureau Chief

Related Showcases

|

view all

  • Neurology

Unrestricted oral feedings reported by caregivers and affected persons across severity of…

  • Conference Coverage & Reporting
  • Neurology

Feasibility of assisted 6-minute cycle test shown in non-ambulatory SMA patients

  • Conference Coverage & Reporting
  • Neurology

Nusinersen treatment may improve aerobic capacity in adult SMA patients

  • Conference Coverage & Reporting
  • Neurology

Treatment linked to continued stabilization of motor function in adults with SMA

  • Conference Coverage & Reporting
  • Neurology

Study identifies miRNAs upregulated in SMA

  • Conference Coverage & Reporting
  • Neurology

EAN 2020 | Teriflunomide shows benefits in children with relapsing forms of…

  • Conference Coverage & Reporting

Building relationships through trusted content for healthcare professionals

GET STARTED
A global leader in medical content

© 2023 Springer Healthcare Limited.
Part of the Springer Nature Group.

Twitter Icon-social_rss
Social Share
Contact
eAlerts
Register
Login
Terms of Use
Privacy Policy
Cookie Policy